Startups
MISSION Therapeutics

MISSION Therapeutics

https://missiontherapeutics.com

Deubiquitylating enzyme (DUB) drug discovery and development platform.

Summary

Seedtable Score
  • 26
Locations
Company Size
  • 51 to 100 employees
Last Stage Round
  • Series B
Industry

Total funding Amount

$180M

Fundraising History

  • Mar 14 '24 Series B
    $32M
  • Jul 06 '20 Series C
    $15M
  • Feb 02 '16 Series C
    $76M
  • Nov 18 '13 Series B
    $25M
  • Aug 24 '11 Series A
    $6M

Investors

  • Sofinnova Partners
    Series A
  • Rosetta Capital
    Series B
  • Pfizer Venture Investments
    Series B
  • IP Group
    Series B
  • Roche Venture Fund
    Series A